The antimicrobial stewardship program was implemented at the hospital in July 2001. It relied heavily on a multidisciplinary team comprised of a clinical pharmacist trained in infectious diseases and a part-time infectious diseases physician who monitored antimicrobial orders and conducted interventions and education.
Researchers at the hospital found the program led to a 45.8 percent decrease in utilization costs, from $44,181 per 1,000 patient-days in 2001 to $23,933 per 1,000 patient-days in 2008. The first three years of the program saw a reduction of approximately $3 million, mainly from a decrease use of antifungal agents for cancer patients. When the program was discontinued in 2008, antimicrobial costs rose 32 percent in two years.
Related Articles on Antimicrobial Stewardship:
8 Recent Stories on Infection Control
Auditing, Feedback May Encourage More Appropriate Antibiotic Use
At the Becker's 11th Annual IT + Revenue Cycle Conference: The Future of AI & Digital Health, taking place September 14–17 in Chicago, healthcare executives and digital leaders from across the country will come together to explore how AI, interoperability, cybersecurity, and revenue cycle innovation are transforming care delivery, strengthening financial performance, and driving the next era of digital health. Apply for complimentary registration now.
